The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity

The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity

PIK3R1 (also known as p85α) is a regulatory subunit of phosphoinositide 3-kinases (PI3Ks). PI3K, a heterodimer of a regulatory subunit and a catalytic subunit, phosphorylates phosphatidylinositol into secondary signaling molecules involved in regulating metabolic homeostasis. PI3K converts phosphati...

Full description

Bibliographic Details
Main Authors:	Ariel Tsay, Jen-Chywan Wang
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	International Journal of Molecular Sciences
Subjects:	phosphoinositide 3-kinases (PI3K) PIK3R1 p85α, insulin signaling insulin resistance type 2 diabetes metabolic disorders
Online Access:	https://www.mdpi.com/1422-0067/24/16/12665

Similar Items

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients
by: Shujiao He, et al.
Published: (2017-12-01)

Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice
by: Feiya Ma, et al.
Published: (2017-01-01)

Dietary curcumin enhances insulin clearance in diet-induced obese mice via regulation of hepatic PI3K-AKT axis and IDE, and preservation of islet integrity
by: Yoo Kim, et al.
Published: (2019-07-01)

Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
by: Gillian L. Dornan, et al.
Published: (2018-03-01)

Immunodeficiency due to a novel variant in PIK3CD: a case report
by: Niloofar Shashaani, et al.
Published: (2023-07-01)

Novel PIK3R1 mutation of SHORT syndrome: A case report with a 6‐month follow up
by: Xiaofei Yin, et al.
Published: (2021-10-01)

PI3Kγ Regulatory Protein p84 Determines Mast Cell Sensitivity to Ras Inhibition—Moving Towards Cell Specific PI3K Targeting?
by: Julie R. Jin, et al.
Published: (2020-10-01)

Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
by: Biqin Zhang, et al.
Published: (2021-11-01)

Structural Determinants of Isoform Selectivity in PI3K Inhibitors
by: Michelle S. Miller, et al.
Published: (2019-02-01)

Divergent roles of the regulatory subunits of class IA PI3K
by: Cho-Won Kim, et al.
Published: (2024-01-01)

Mouse Models for Exploring the Biological Consequences and Clinical Significance of <i>PIK3CA</i> Mutations
by: Camilla B. Mitchell, et al.
Published: (2019-04-01)

Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
by: Ebru Aydin, et al.
Published: (2021-01-01)

PI3K inhibitors in thrombosis and cardiovascular disease
by: Tom N. Durrant, et al.
Published: (2020-01-01)

Case Report: Activating PIK3CD Mutation in Patients Presenting With Granulomatosis With Polyangiitis
by: Meiping Lu, et al.
Published: (2021-04-01)

circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway
by: Hongcheng Luo, et al.
Published: (2021-12-01)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
by: Katherine E. Hutchinson, et al.
Published: (2023-04-01)

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype
by: Peiwei Zhao, et al.
Published: (2024-01-01)

Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”
by: Niamh M. Keegan, et al.
Published: (2021-03-01)

Activated PI3Kinase Delta Syndrome—A Multifaceted Disease
by: Romane Thouenon, et al.
Published: (2021-06-01)

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
by: Liying Yang, et al.
Published: (2018-02-01)

Mapping the PIK3CA-related overgrowth spectrum (PROS) patient and caregiver journey using a patient-centered approach
by: Lara Rodríguez-Laguna, et al.
Published: (2022-05-01)

TCF7L2 regulates pancreatic β-cell function through PI3K/AKT signal pathway
by: Hui-Hui Wu, et al.
Published: (2019-07-01)

The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer
by: Anna Passarelli, et al.
Published: (2023-01-01)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
by: Maria Elena Maccari, et al.
Published: (2018-03-01)

Highly frequent <it>PIK3CA </it>amplification is associated with poor prognosis in gastric cancer
by: Shi Jing, et al.
Published: (2012-02-01)

Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
by: Noah J Harris, et al.
Published: (2023-07-01)

circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer
by: Yao Kong, et al.
Published: (2020-05-01)

The role of PIK3CA mutations in the development of breast cancer (a literature review)
by: A. O. Pryvalova, et al.
Published: (2020-08-01)

Effect of an Aerobic Exercise Course on PI3K and AKT1 Expression and Neural Muscle Insulin Resistance in Diabetic Rats
by: Mahdi Nadi, et al.
Published: (2021-09-01)

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
by: Guillaume Canaud, et al.
Published: (2021-07-01)

LncRNA HOTAIR regulates the PI3K/AKT pathway via the miR‐126‐3p/PIK3R2 axis to participate in synovial angiogenesis in rheumatoid arthritis
by: Feifei Liu, et al.
Published: (2023-10-01)

Phosphoinositide 3-Kinases as Potential Targets for Thrombosis Prevention
by: Natasha M. Setiabakti, et al.
Published: (2022-04-01)

Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta Syndromes
by: Vyanka Redenbaugh, et al.
Published: (2021-08-01)

<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma
by: Concetta D’Ambrosio, et al.
Published: (2020-02-01)

Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
by: Shutao Zheng, et al.
Published: (2024-04-01)

Detection of „Hotspot Mutations in Catalytic Subunit of Phosphatidylinositol 3-Kinase (Pik3ca) by Allele-Specific Polymerase Chain Reaction
by: A. Mendelova, et al.
Published: (2014-09-01)

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
by: Irina V. Poddubnaya, et al.
Published: (2021-02-01)

Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells
by: Marzia Di Donato, et al.
Published: (2022-08-01)

The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis
by: María Montes-Casado, et al.
Published: (2021-06-01)

Astaxanthin Inhibits p70 S6 Kinase 1 Activity to Sensitize Insulin Signaling
by: Chunmei Li, et al.
Published: (2020-09-01)